PHMB, amphotericin B, and voriconazole were used as antiamoebic drugs to determine whether antiamoebic drugs have a synergistic effect with PDT. PHMB was diluted in 1/4 Ringer's solution to obtain test solutions with final concentrations of 1, 2.5, 5, 10, 25, 50, and 100 ppm. Amphotericin B (Fungizone; Bristol-Myers K.K., Tokyo, Japan) was reconstituted in sterile Millipore-filtered water and diluted to concentrations of 100, 200, 400, 800, and 1600 μg/mL. Voriconazole (Vfend; Pfizer, Tokyo, Japan) was reconstituted in sterile Millipore-filtered water and diluted to concentrations of 40, 100, 400, 1000, 4000, and 10,000 μg/mL. To evaluate the effect of each antiamoebic drug alone, 4 × 106 trophozoites were incubated in different concentrations of each antiamoebic drug for 60 minutes. Then the cells were washed and the CTC biocidal assay was performed. Based on the results of preliminary experiments with MB and antiamoebic drug monotherapy, sublethal concentrations of each solution were selected to test in combination against trophozoites, to evaluate for a synergistic effect. To assess the effect of combination therapy, 4 × 106 trophozoites were incubated with each antiamoebic drug for 60 minutes, washed with PBS twice, incubated with MB solution in the dark for 10 minutes, and irradiated as described above. After irradiation at 10.8 J/cm2 (or nonirradiation), cells were collected from dishes and the CTC biocidal assay was performed.